Open an account

Perrigo

PRGO · NYSE

$16.17+$0.08 (+0.50%)TodayMarket closed ·
Prev close $16.09

About PRGO

Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

Employees
8,100
Headquarters
DUBLIN, Dublin
Listed
Dec 17, 1991
Sector
Health Care
Industry
Pharmaceuticals
Website
perrigo.com

PRGO key statistics

Market cap
2.24B
Price-earnings ratio
0.00
Dividend yield
7.10%
Average volume
2.87M
Volume
1.77M
Open price
$16.34
High today
$16.68
Low today
$16.08
52 Week high
$22.02
52 Week low
$9.23

Perrigo (PRGO) at a glance

As of Oct 20, 2026, Perrigo (PRGO) shares are priced at $16.17, giving the company a market cap of 2.24B, a price-to-earnings ratio of 0.00 and a dividend yield of 7.10%.

Today the stock has traded between $16.08 and $16.68. The current price is 0.6% above the day's low and 3.1% below its high.

Volume so far is 1.77M shares, below the average of 2.87M shares a day.

Over the past year Perrigo has ranged from $9.23 to $22.02, and now sits 54% of the way up that range.

Perrigo met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.50 per share against an estimate of $0.3492.

The average analyst price target is $15.81, 2.2% below the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 3 analyst ratings say Buy
  • Buy33.3%
  • Hold66.7%
  • Sell0.0%
Price target · 5 analystsAvg $15.81
Low
$14.14
Now
$16.17
High
$17.85

PRGO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 22.3% on average.

  1. Q3 FY24: reported $0.81 per share against an estimate of $0.8275
  2. Q4 FY24: reported $0.93 per share against an estimate of $0.9435
  3. Q1 FY25: reported $0.60 per share against an estimate of $0.5585
  4. Q2 FY25: reported $0.57 per share against an estimate of $0.6052
  5. Q3 FY25: reported $0.80 per share against an estimate of $0.7694
  6. Q4 FY25: reported $0.788 per share against an estimate of $0.7993
  7. Q1 FY26: reported $0.43 per share against an estimate of $0.3196
  8. Q2 FY26: reported $0.50 per share against an estimate of $0.3492

PRGO news

  • Press releasePRNewswire

    Perrigo to Attend the Barclays Global Consumer Conference

  • Avi Kapoor

    Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releasePRNewswire

    Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations

  • Press releasePRNewswire

    Perrigo Announces Quarterly Dividend

  • Press releasePRNewswire

    Perrigo to Present at the Canaccord 46th Annual Growth Conference

  • Press releasePRNewswire

    Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026

  • Press releasePRNewswire

    Perrigo Announces Appointment of Two New Independent Directors to Board

Similar companies

Companies in the same industry as Perrigo

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.